← Leaderboards
Raymond F Anton
Medical University Of South Carolina
$17,048,886
Attributed
$17,048,886
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$17,048,886 · 14
By mechanism
R01$7,729,033 · 3
P50$4,540,284 · 7
K05$2,196,688 · 1
U10$1,940,852 · 1
R21$365,322 · 1
T32$276,707 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Peter M Miller$3,526,722
- Bernadette Cortese$2,280,439
- Lawrence D Middaugh$1,886,142
- Carrie L Randall$7,544,353
- Lynne S. Nemeth$576,896
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsCravingDrinkingAlcoholsNaltrexoneAlcohol DependenceBrainPlacebosAlcohol Abuse TherapyFutureRandomizedFunctional Magnetic Resonance ImagingPharmaceutical PreparationsGeneticAreaRelapseVariantProblem DrinkerGenetic VariantResponseNeuroimagingHeavy DrinkingAlcohol CueBrain Imaging
Grant awards (60)
Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control$211,909
P50 · FY2020 · AA · contact PI
Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control$250,250
P50 · FY2019 · AA · contact PI
Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control$219,370
P50 · FY2018 · AA · contact PI
Gabapentin for Relapse Prevention: Alc. Withdrawal-Brain GABA/Glutamate Effects$512,402
R01 · FY2017 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$216,225
K05 · FY2017 · AA · contact PI
Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control$192,021
P50 · FY2017 · AA · contact PI
Gabapentin for Relapse Prevention: Alc. Withdrawal-Brain GABA/Glutamate Effects$524,825
R01 · FY2016 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$216,225
K05 · FY2016 · AA · contact PI
Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control$203,623
P50 · FY2016 · AA · contact PI
Gabapentin for Relapse Prevention: Alc. Withdrawal-Brain GABA/Glutamate Effects$509,080
R01 · FY2015 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$216,225
K05 · FY2015 · AA · contact PI
RC4 IMPULSIVITY AND DRINKING/CRAVING: EFFECT OF A DOPAMINE STABILIZER MEDICATION$203,810
P50 · FY2015 · AA · contact PI
Gabapentin for Relapse Prevention: Alc. Withdrawal-Brain GABA/Glutamate Effects$497,722
R01 · FY2014 · AA · contact PI
RC4 IMPULSIVITY AND DRINKING/CRAVING: EFFECT OF A DOPAMINE STABILIZER MEDICATION$224,455
P50 · FY2014 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$209,738
K05 · FY2014 · AA · contact PI
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism$40,543
R01 · FY2014 · AA · contact PI
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism$469,378
R01 · FY2013 · AA · contact PI
RC4 IMPULSIVITY AND DRINKING/CRAVING: EFFECT OF A DOPAMINE STABILIZER MEDICATION$218,002
P50 · FY2013 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$216,225
K05 · FY2013 · AA · contact PI
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism$512,417
R01 · FY2012 · AA · contact PI
RC4 IMPULSIVITY AND DRINKING/CRAVING: EFFECT OF A DOPAMINE STABILIZER MEDICATION$243,997
P50 · FY2012 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$224,410
K05 · FY2012 · AA · contact PI
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism$525,488
R01 · FY2011 · AA · contact PI
RC4 IMPULSIVITY AND DRINKING/CRAVING: EFFECT OF A DOPAMINE STABILIZER MEDICATION$228,299
P50 · FY2011 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$224,410
K05 · FY2011 · AA · contact PI
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism$546,720
R01 · FY2010 · AA · contact PI
Evaluating the Genetic Variability of Naltrexone Response$272,962
P50 · FY2010 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$224,410
K05 · FY2010 · AA · contact PI
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism$508,954
R01 · FY2009 · AA · contact PI
Evaluating the Genetic Variability of Naltrexone Response$282,615
P50 · FY2009 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$224,410
K05 · FY2009 · AA · contact PI
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence$164,451
R21 · FY2009 · AA · contact PI
Evaluating the Genetic Variability of Naltrexone Response$285,067
P50 · FY2008 · AA · contact PI
Career Development and Mentoring in Clinical/Translational Alcohol Research$224,410
K05 · FY2008 · AA · contact PI
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence$200,871
R21 · FY2008 · AA · contact PI
Evaluating the Genetic Variability of Naltrexone Response$188,370
P50 · FY2007 · AA · contact PI
Pilot Core$132,329
P50 · FY2007 · AA · contact PI
Pilot Core$75,318
P50 · FY2007 · AA · contact PI
Gabapentin as an Adjunct to Naltrexone for Alcoholism$454,568
R01 · FY2006 · AA · contact PI
Evaluating the Genetic Variability of Naltrexone Response$197,058
P50 · FY2006 · AA · contact PI
Pilot Core$182,258
P50 · FY2006 · AA · contact PI
Gabapentin as an Adjunct to Naltrexone for Alcoholism$497,403
R01 · FY2005 · AA
Gabapentin as an Adjunct to Naltrexone for Alcoholism$472,747
R01 · FY2004 · AA
Naltrexonel/Acamprosate and CBT/MET Light for Alcoholism$280,015
U10 · FY2004 · AA
Naltrexonel/Acamprosate and CBT/MET Light for Alcoholism$26,696
U10 · FY2004 · AA
Gabapentin as an Adjunct to Naltrexone for Alcoholism$463,378
R01 · FY2003 · AA
Naltrexonel/Acamprosate and CBT/MET Light for Alcoholism$393,515
U10 · FY2003 · AA
Gabapentin as an Adjunct to Naltrexone for Alcoholism$461,144
R01 · FY2002 · AA
NALTREXONE/ACAMPROSATE PLUS CBT/MET LIGHT FOR ALCOHOLISM$413,542
U10 · FY2002 · AA
EFFECT OF NALTREXONE AND ONDANSETRON ON ALCOHOLISM$242,857
P50 · FY2002 · AA
EFFECT OF NALTREXONE AND ONDANSETRON ON ALCOHOLISM$242,857
P50 · FY2002 · AA
TRAINING IN ALCOHOL TREATMENT RESEARCH$81,966
T32 · FY2002 · AA
NALTREXONE/ACAMPROSATE PLUS CBT/MET LIGHT FOR ALCOHOLISM$413,542
U10 · FY2001 · AA
COMPARISON OF CBT AND MET PLUS NALTREXONE FOR ALCOHOLISM$371,377
R01 · FY2001 · AA
TRAINING IN ALCOHOL TREATMENT RESEARCH$56,465
T32 · FY2001 · AA
EFFECT OF NALTREXONE AND ONDANSETRON ON ALCOHOLISM$0
P50 · FY2001 · AA
NALTREXONE/ACAMPROSATE PLUS CBT/MET LIGHT FOR ALCOHOLISM$413,542
U10 · FY2000 · AA
COMPARISON OF CBT AND MET PLUS NALTREXONE FOR ALCOHOLISM$360,887
R01 · FY2000 · AA
OPIATE ANTAGONIST--ALCOHOL REACTIVITY AND CONSUMPTION$242,857
P50 · FY2000 · AA
TRAINING IN ALCOHOL TREATMENT RESEARCH$138,276
T32 · FY2000 · AA